Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
AMN Healthcare Services Inc Market Cap
Based on ratings from 8 stock analysts, the AMN Healthcare Services Inc stock price is expected to increase by 52.17% in 12 months. This is calculated by using the average 12-month stock price forecast for AMN Healthcare Services Inc. The lowest target is $43 and the highest is $71. Please note analyst price targets are not guaranteed and could be missed completely.
AMN Healthcare Services Inc has a total of 8 Wall St Analyst ratings. There are 8 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that AMN Healthcare Services Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of AMN.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Kevin Fischbeck B of A Securities | Underperform | $48 | Downgrade | Oct 7, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $66 | Reiterates | Oct 4, 2024 |
| Bill Sutherland Benchmark | Hold | Reiterates | Oct 2, 2024 | |
| Constantine Davides JMP Securities | Market Outperform | $66 | Maintains | Aug 13, 2024 |
| Jeffrey Silber BMO Capital | Outperform | $71 | Maintains | Aug 12, 2024 |
| A.J. Rice UBS | Neutral | $65 | Maintains | Aug 9, 2024 |
| Bill Sutherland Benchmark | Hold | Reiterates | May 28, 2024 | |
| Kevin Fischbeck B of A Securities | Neutral | $65 | Maintains | May 15, 2024 |
| Jeffrey Silber BMO Capital | Outperform | $71 | Maintains | May 13, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $75 | Reiterates | May 10, 2024 |
| Bill Sutherland Benchmark | Hold | Reiterates | May 2, 2024 | |
| Tobey Sommer Truist Securities | Buy | $70 | Maintains | Apr 22, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $75 | Maintains | Feb 26, 2024 |
| Jeffrey Silber BMO Capital | Outperform | $83 | Maintains | Feb 20, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $87 | Maintains | Feb 16, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $85 | Initiates | Dec 6, 2023 |
| Tobey Sommer Truist Securities | Buy | $88 | Reiterates | Dec 5, 2023 |
| A.J. Rice UBS | Neutral | $73 | Initiates | Nov 30, 2023 |
| Tobey Sommer Truist Securities | Buy | $88 | Maintains | Nov 6, 2023 |
| Bill Sutherland Benchmark | Hold | Downgrade | Nov 3, 2023 |
When did it IPO
2001
Staff Count
3,585
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Ms. Caroline Sullivan Grace
Market Cap
$1.47B
In 2023, AMN generated $3.79B in revenue, which was a decrease of -27.73% from the previous year. This can be seen as a signal that AMN's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Tue, 08 Oct 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - AMN Healthcare has launched a new initiative to enhance staffing efficiency and improve operational efficiency in healthcare systems.
Why It Matters - AMN Healthcare's initiative to improve staffing and operational efficiency could lead to higher profitability and better service delivery, positively impacting its stock performance and investor sentiment.
Tue, 08 Oct 2024
Sentiment - POSITIVE
Source - Benzinga
Summary - The health care sector has identified several oversold stocks, indicating potential buying opportunities for investors looking for undervalued companies.
Why It Matters - Oversold stocks in health care indicate potential undervaluation, creating buying opportunities that may lead to future price rebounds and improved investment returns.
Fri, 04 Oct 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - AMN demonstrates growth potential due to broad services and high demand, but faces challenges from industry regulations and strong competition in staffing.
Why It Matters - AMN's growth potential indicates opportunity, but regulatory challenges and competition could impact profitability and market share, affecting stock performance and long-term investment decisions.
Tue, 01 Oct 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - AMN Healthcare's CFO, Jeffrey Knudson, will resign effective November 8, 2024. The company plans to appoint a successor for an expanded CFO/COO role before his departure.
Why It Matters - Leadership changes can impact investor confidence and stock performance. The new CFO/COO could bring different strategies, affecting AMN's direction and financial health.
Thu, 03 Oct 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - A seasoned healthcare executive with over 10 years of financial strategy experience, including roles as CFO and Chief Accounting Officer at AMN, has joined the company.
Why It Matters - The appointment of an experienced healthcare executive with a strong financial background signals potential for improved financial performance and strategic growth, influencing stock valuations positively.
Wed, 02 Oct 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - A new all-in-one technology solution aims to improve staffing efficiency, financial planning, and operational efficiency in healthcare systems by managing both internal and external talent.
Why It Matters - The news highlights advancements in healthcare technology that can lead to cost savings and improved margins, indicating potential growth and profitability for companies in this sector.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
